Cargando…

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

SIMPLE SUMMARY: Prostate Cancer (PC) is currently estimated to affect 1 in 9 men and is the second leading cause of cancer in men in the US. While androgen deprivation therapy, which targets the androgen receptor, is one of the front-line therapies for advanced PC and for recurrence of organ-confine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beinhoff, Paul, Sabharwal, Lavannya, Udhane, Vindhya, Maranto, Cristina, LaViolette, Peter S., Jacobsohn, Kenneth M., Tsai, Susan, Iczkowski, Kenneth A., Wang, Liang, Hall, William A., Dehm, Scott M., Kilari, Deepak, Nevalainen, Marja T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533841/ https://www.ncbi.nlm.nih.gov/pubmed/34680353 http://dx.doi.org/10.3390/cancers13205204

Ejemplares similares

Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo
por: Maranto, Cristina, et al.
Publicado: (2020)

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
por: Hoang, David T, et al.
Publicado: (2016)

Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer
por: McGarry, Sean D., et al.
Publicado: (2018)

Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging
por: Hurrell, Sarah L., et al.
Publicado: (2017)

2555 Predictive cytological topography (PiCT): A radiopathomics approach to mapping prostate cancer
por: McGarry, Sean D., et al.
Publicado: (2018)

Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth
por: Duenweg, Savannah R., et al.
Publicado: (2022)

Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space
por: McGarry, Sean D., et al.
Publicado: (2019)

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence
por: Duenweg, Savannah R., et al.
Publicado: (2023)

COVID-19: Are We Ready for the Second Wave?
por: Ali, Inayat
Publicado: (2020)

Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology
por: Duenweg, Savannah R., et al.
Publicado: (2023)

Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology
por: Duenweg, Savannah R., et al.
Publicado: (2023)

Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer
por: McGarry, Sean D., et al.
Publicado: (2020)

Minimally invasive donor hepatectomy, are we ready for prime time?
por: Au, Kin Pan, et al.
Publicado: (2018)

Are we ready?()
por: Pedrosa, C.
Publicado: (2020)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020)

An overview of digital readiness in dentistry - are we ready?
por: Dickenson, Andrew, et al.
Publicado: (2022)

Are We Ready for Anything?
por: Neal-Boylan, Leslie
Publicado: (2020)

Are We Ready for Migrastatics?
por: Solomon, Jonathan, et al.
Publicado: (2021)

We are Ready for 2024!
Publicado: (2023)

Activating Mutation (V617F) in the Tyrosine Kinase JAK2 is Absent in Locally-Confined or Castration-Resistant Prostate Cancer
por: Gu, Lei, et al.
Publicado: (2010)

QCD: are we ready for the LHC?
por: Frixione, Stefano
Publicado: (2006)

Are we ready for submental diversions?
por: Kundra, Pankaj, et al.
Publicado: (2016)

The World is Changing – Are We Ready?
Publicado: (2016)

Pandemic Influenza: Are We Ready?
por: Cinti, Sandro
Publicado: (2005)

Avian Influenza: Are We Ready?
por: Krau, Stephen D., et al.
Publicado: (2007)

Avian flu: Are we ready?
por: Aldhous, Peter, et al.
Publicado: (2005)

Are we ready for the new coronavirus?()
por: Peña-Otero, David, et al.
Publicado: (2020)

Personalised medicine: are we ready?
por: Louis, Renaud, et al.
Publicado: (2017)

Bioinformatics and the Metaverse: Are We Ready?
por: Taylor, Stephen, et al.
Publicado: (2022)

When a COVID-19 vaccine is ready, will we all be ready for it?
por: Fadda, Marta, et al.
Publicado: (2020)

NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
por: Sun, Yunguang, et al.
Publicado: (2021)

“Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?
por: Karacin, Cengiz, et al.
Publicado: (2021)

Therapeutic targeting of JAKs: from hematology to rheumatology and from the first to the second generation of JAK inhibitors
por: Bertsias, George
Publicado: (2020)

Atrial Fibrillation Ablation - Are we ready?
por: Deshpande, Shantanu, et al.
Publicado: (2007)

Microbe: Are We Ready for the Next Plague?
por: Jahrling, Peter B.
Publicado: (2005)

Are we ready for the 2009 beam operation?
por: Redaelli, S, et al.
Publicado: (2009)

ARE WE READY FOR ARABIZATION IN MEDICAL EDUCATION?
por: Ismail, Hassan M.
Publicado: (2002)

Infection and Chemotherapy: We Are Ready to Fly
por: Cheong, Hee Jin
Publicado: (2013)

The flu pandemic: were we ready?
Publicado: (2005)

Will we be judged ready for the influenza pandemic?
por: Racette, Ray J.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3hp2lnr8ahiaq20vuua19rj5lj